261 results on '"Gill, Hartej"'
Search Results
2. Correction: Subjective and objective measures of cognitive function are correlated in persons with Post-COVID-19 Condition: a secondary analysis of a Randomized Controlled Trial
3. Association between rumination, suicidal ideation and suicide attempts in persons with depressive and other mood disorders and healthy controls: A systematic review and meta-analysis
4. Electroencephalography (EEG) spectral signatures of selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs) and vortioxetine in major depressive disorder: A systematic review
5. Metabolic factors modulate effort-based decision-making in major depressive disorder
6. Association between cognitive functioning, suicidal ideation and suicide attempts in major depressive disorder, bipolar disorder, schizophrenia and related disorders: A systematic review and meta-analysis
7. Glucagon-like peptide 1 agonist and effects on reward behaviour: A systematic review
8. Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review
9. Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review
10. COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis
11. Evaluating the Use of Glucagon-Like Peptide 1 for the Treatment of Cognitive Dysfunction in Individuals with Mood Disorders
12. Evaluating the neural substrates of effort-expenditure for reward in adults with major depressive disorder and obesity
13. Exploring community-based research values and principles: Lessons learned from a Delphi study
14. A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review
15. The effect of adjunctive infliximab treatment on future cardiovascular disease risk in patients with bipolar disorder
16. Evaluating cognitive function in unaffected relatives of individuals with bipolar disorders: A meta-analysis
17. The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies
18. Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis
19. Immune response to vaccination in adults with mental disorders: A systematic review
20. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis
21. Prevalence of type 2 diabetes mellitus, impaired fasting glucose, general obesity, and abdominal obesity in patients with bipolar disorder: A systematic review and meta-analysis
22. The effects of antidepressant medications on antiretroviral treatment adherence in HIV-positive individuals with depression
23. Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: Results from the canadian rapid treatment center of excellence
24. Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression
25. Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effects
26. The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine
27. Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of Excellence
28. Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review
29. Does pre-treatment functioning influence response to intravenous ketamine in adults with treatment-resistant depression?
30. The effect of intravenous ketamine on cognitive functions in adults with treatment-resistant major depressive or bipolar disorders: Results from the Canadian rapid treatment center of excellence (CRTCE)
31. Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countries
32. Registered clinical studies investigating psychedelic drugs for psychiatric disorders
33. The Prevalence of Suicidal Behaviour in Fibromyalgia Patients
34. The effect of repeated doses of intravenous ketamine on measures of workplace attendance and productivity in adults with major depressive and bipolar disorder: Results from the canadian rapid treatment center of excellence
35. Validation of the McIntyre And Rosenblat Rapid Response Scale (MARRRS) in Adults with Treatment-Resistant Depression Receiving Intravenous Ketamine Treatment
36. Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders
37. A Systematic review of the validity of screening depression through Facebook, Twitter, Instagram, and Snapchat
38. The impact of overweight/obesity on monetary reward processing: A systematic review
39. Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: A systematic review
40. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review
41. Loneliness-based impaired reward system pathway: Theoretical and clinical analysis and application
42. Intravenous ketamine for postmenopausal women with treatment-resistant depression: Results from the Canadian Rapid Treatment Center of Excellence
43. Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence
44. A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusions
45. Insulin resistance is associated with deficits in hedonic, self-reported cognitive, and psychosocial functional response to antidepressant treatment in individuals with major depressive disorder
46. Ecological momentary assessment of depressive symptoms using the mind.me application: Convergence with the Patient Health Questionnaire-9 (PHQ-9)
47. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis
48. Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment
49. The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future Research
50. Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.